Skip to main content
SpringerLink
Log in

Follow-Up and Monitoring of Adrenocortical Carcinoma

  • Chapter
  • First Online:
Adrenocortical Carcinoma

  • 618 Accesses

Abstract

Patients with adrenocortical carcinoma (ACC) usually present with (1) symptoms caused by tumor growth and/or (2) hormone production or (3) ACC is discovered incidentally by imaging conducted for reasons other than suspicion of an adrenocortical tumor. Recurrent ACC will therefore mainly be discovered by detection of tumor growth, which can occur at the former resection site or present as distant metastases, by recurrence of symptoms of hormone access, or by biochemical evidence of rising hormone levels produced by the tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Strosberg JR et al (2009) Management of adrenocortical carcinoma. J Natl Compr Canc Netw 7(7):752–758; quiz 759

    CAS  PubMed  Google Scholar 

  2. Clark OH et al (2009) NCCN clinical practice guidelines in oncology: neuroendocrine tumors. J Natl Compr Canc Netw 7(7):712–747

    CAS  PubMed  Google Scholar 

  3. Schteingart DE et al (2005) Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12(3):667–680

    Article  CAS  PubMed  Google Scholar 

  4. Doherty GM et al (1990) Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing’s syndrome. Surgery 108:1085–1090

    CAS  PubMed  Google Scholar 

  5. Kikuchi E et al (2000) Urinary steroid profile in adrenocortical tumors. Biomed Pharmacother 54(Suppl 1):194s–197s

    Article  CAS  PubMed  Google Scholar 

  6. Grondal S et al Steroid profile in urine: a useful tool in the diagnosis and follow up of adrenocortical carcinoma. Acta Endocrinol 122(5):656–663

    Google Scholar 

  7. Butt Z et al (2008) Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. J Natl Compr Canc Netw 6(5):448–455

    PubMed  Google Scholar 

  8. Mock V et al (2007) Cancer-related fatigue. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 5(10):1054–1078

    PubMed  Google Scholar 

  9. Hall EJ, Brenner DJ (2008) Cancer risks from diagnostic radiology. Br J Radiol 81(965):362–378

    Article  CAS  PubMed  Google Scholar 

  10. Podoloff DA et al (2009) NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw 7(Suppl 2):S1–26

    PubMed  Google Scholar 

  11. Razifar P et al (2009) Masked volume wise principal component analysis of small adrenocortical tumours in dynamic [11C]-metomidate positron emission tomography. BMC Med Imaging 9:6

    Google Scholar 

  12. Khan TS et al (2003) 11C-metomidate PET imaging of adrenocortical cancer. Eur J Nucl Med Mol Imaging 30(3):403–410

    Article  PubMed  Google Scholar 

  13. Miller BS et al (2010) Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma. World J Surg 34(6):1380–1385

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrine Oncology, Uppsala University Hospital, University of Uppsala, Akademiska sjukhuset/Uppsala, SE-751 85, Uppsala, Sweden

    Britt Skogseid

  2. Department of Surgery, University of Michigan Health System, The University of Michigan, 2920 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, USA

    Gerard M. Doherty

Authors
  1. Britt Skogseid
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerard M. Doherty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerard M. Doherty .

Editor information

Editors and Affiliations

  1. Zina Pitcher Place 109, Ann Arbor, 48109-2200, Michigan, USA

    Gary D. Hammer

  2. Dept. Internal Medicine, Div. Pulmonary & Critical Care Medicine, University of Michigan Health System, Zina Pitcher Place 109, Ann Arbor, 48109-2200, Michigan, USA

    Tobias Else

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Skogseid, B., Doherty, G.M. (2009). Follow-Up and Monitoring of Adrenocortical Carcinoma. In: Hammer, G., Else, T. (eds) Adrenocortical Carcinoma. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77236-3_26

Download citation

Publish with us

Policies and ethics

Search

Navigation